These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2421329)

  • 21. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 26. Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.
    Coffin CM; Ewing S; Dehner LP
    Arch Pathol Lab Med; 1985 Jun; 109(6):555-9. PubMed ID: 2581525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 28. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor markers and pathology of testicular tumors.
    Mostofi FK
    Prog Clin Biol Res; 1984; 153():69-87. PubMed ID: 6206511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
    [No Abstract]   [Full Text] [Related]  

  • 32. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
    Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
    Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis, diagnosis and therapy of testicular tumors].
    Weissbach I; Bussar-Maatz R
    Urologe A; 1996 Mar; 35(2):163-72. PubMed ID: 8650851
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.
    Hoskin P; Dilly S; Easton D; Horwich A; Hendry W; Peckham MJ
    J Clin Oncol; 1986 Jul; 4(7):1031-6. PubMed ID: 2425060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistological evaluation of AFP and hCG in germ cell tumors].
    Kimura N; Namiki T; Wada T; Kuwabara K; Morizuka T; Sasano N
    Gan No Rinsho; 1982; 28(1):34-42. PubMed ID: 6190018
    [No Abstract]   [Full Text] [Related]  

  • 38. Current concepts in risk factor assessment for advanced germ cell cancer.
    Garzotto M; Nichols CR
    Semin Urol Oncol; 2001 Aug; 19(3):165-9. PubMed ID: 11561983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemistry and search for a functional classification of germ cell tumours.
    Hustin J; Franchimont P
    Acta Urol Belg; 1985; 53(2):223-37. PubMed ID: 2409782
    [No Abstract]   [Full Text] [Related]  

  • 40. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.